373 related articles for article (PubMed ID: 26040705)
1. Sirolimus for the treatment of children with various complicated vascular anomalies.
Lackner H; Karastaneva A; Schwinger W; Benesch M; Sovinz P; Seidel M; Sperl D; Lanz S; Haxhija E; Reiterer F; Sorantin E; Urban CE
Eur J Pediatr; 2015 Dec; 174(12):1579-84. PubMed ID: 26040705
[TBL] [Abstract][Full Text] [Related]
2. Sirolimus in the Treatment of Vascular Anomalies.
Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
[No Abstract] [Full Text] [Related]
3. Treatment of voluminous and complicated superficial slow-flow vascular malformations with sirolimus (PERFORMUS): protocol for a multicenter phase 2 trial with a randomized observational-phase design.
Maruani A; Boccara O; Bessis D; Guibaud L; Vabres P; Mazereeuw-Hautier J; Barbarot S; Chiaverini C; Blaise S; Droitcourt C; Mallet S; Martin L; Lorette G; Woillard JB; Jonville-Bera AP; Rollin J; Gruel Y; Herbreteau D; Goga D; le Touze A; Leducq S; Gissot V; Morel B; Tavernier E; Giraudeau B;
Trials; 2018 Jun; 19(1):340. PubMed ID: 29945674
[TBL] [Abstract][Full Text] [Related]
4. Sirolimus for the treatment of complicated vascular anomalies in children.
Hammill AM; Wentzel M; Gupta A; Nelson S; Lucky A; Elluru R; Dasgupta R; Azizkhan RG; Adams DM
Pediatr Blood Cancer; 2011 Dec; 57(6):1018-24. PubMed ID: 21445948
[TBL] [Abstract][Full Text] [Related]
5. [Our experience with sirolimus for the treatment of complicated vascular anomalies].
Giménez-Aleixandre C; Méndez-Aguirre NA; Martínez-Menchón T; Girón Vallejo Ó; Fernández-Ibieta M; Ferri-Ñíguez B; Villamil V; Sánchez-Sánchez Á; Montoya-Rangel CA; Hernández-Bermejo JP
Cir Pediatr; 2019 Jan; 32(1):28-33. PubMed ID: 30714698
[TBL] [Abstract][Full Text] [Related]
6. Vascular Anomalies: Diagnosis of Complicated Anomalies and New Medical Treatment Options.
Adams DM; Ricci KW
Hematol Oncol Clin North Am; 2019 Jun; 33(3):455-470. PubMed ID: 31030813
[TBL] [Abstract][Full Text] [Related]
7. Severe adverse events during sirolimus "off-label" therapy for vascular anomalies.
Rössler J; Baselga E; Davila V; Celis V; Diociaiuti A; El Hachem M; Mestre S; Haeberli D; Prokop A; Hanke C; Loichinger W; Quéré I; Baumgartner I; Niemeyer CM; Kapp FG
Pediatr Blood Cancer; 2021 Aug; 68(8):e28936. PubMed ID: 33580918
[TBL] [Abstract][Full Text] [Related]
8. A prospective multicenter study of sirolimus for complicated vascular anomalies.
Ji Y; Chen S; Yang K; Zhou J; Zhang X; Jiang X; Xu X; Lu G; Qiu L; Kong F; Zhang Y
J Vasc Surg; 2021 Nov; 74(5):1673-1681.e3. PubMed ID: 34082006
[TBL] [Abstract][Full Text] [Related]
9. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
Shoji MK; Shishido S; Freitag SK
Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
[TBL] [Abstract][Full Text] [Related]
10. Sirolimus for the Treatment of a Massive Capillary-Lymphatico-Venous Malformation: A Case Report.
Vlahovic AM; Vlahovic NS; Haxhija EQ
Pediatrics; 2015 Aug; 136(2):e513-6. PubMed ID: 26148957
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and absorption of topical sirolimus for the treatment of vascular anomalies in children: A case series.
Le Sage S; David M; Dubois J; Powell J; McCuaig CC; Théorêt Y; Kleiber N
Pediatr Dermatol; 2018 Jul; 35(4):472-477. PubMed ID: 29790593
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of sirolimus in the treatment of vascular anomalies: A systematic review.
Freixo C; Ferreira V; Martins J; Almeida R; Caldeira D; Rosa M; Costa J; Ferreira J
J Vasc Surg; 2020 Jan; 71(1):318-327. PubMed ID: 31676179
[TBL] [Abstract][Full Text] [Related]
13. Single-center experience with sirolimus therapy for vascular malformations.
Yesil S; Tanyildiz HG; Bozkurt C; Cakmakci E; Sahin G
Pediatr Hematol Oncol; 2016 Apr; 33(3):219-25. PubMed ID: 27128161
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of sirolimus in children with lymphatic malformations of the head and neck.
Wiegand S; Dietz A; Wichmann G
Eur Arch Otorhinolaryngol; 2022 Aug; 279(8):3801-3810. PubMed ID: 35526176
[TBL] [Abstract][Full Text] [Related]
15. Oral Sirolimus: An Option in the Management of Neonates with Life-Threatening Upper Airway Lymphatic Malformations.
Triana P; Miguel M; Díaz M; Cabrera M; López Gutiérrez JC
Lymphat Res Biol; 2019 Oct; 17(5):504-511. PubMed ID: 30985248
[No Abstract] [Full Text] [Related]
16. Medical management of vascular anomalies.
Trenor CC
Semin Cutan Med Surg; 2016 Sep; 35(3):177-81. PubMed ID: 27607327
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus for management of complex vascular anomalies - A proposed dosing regimen for very young infants.
Czechowicz JA; Long-Boyle JR; Rosbe KW; Mathes EF; Frieden IJ; Shimano KA
Int J Pediatr Otorhinolaryngol; 2018 Feb; 105():48-51. PubMed ID: 29447818
[TBL] [Abstract][Full Text] [Related]
18. [Benign aggressive vascular anomalies in children].
Boccara O; Maruani A; Léauté-Labrèze C
Bull Cancer; 2018 Jun; 105(6):610-625. PubMed ID: 29571951
[TBL] [Abstract][Full Text] [Related]
19. Treatment of superficial vascular anomalies with topical sirolimus: A multicenter case series.
Dodds M; Tollefson M; Castelo-Soccio L; Garzon MC; Hogeling M; Hook K; Boull C; Maguiness S
Pediatr Dermatol; 2020 Mar; 37(2):272-277. PubMed ID: 31957126
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus is efficacious in treatment for extensive and/or complex slow-flow vascular malformations: a monocentric prospective phase II study.
Hammer J; Seront E; Duez S; Dupont S; Van Damme A; Schmitz S; Hoyoux C; Chopinet C; Clapuyt P; Hammer F; Vikkula M; Boon LM
Orphanet J Rare Dis; 2018 Oct; 13(1):191. PubMed ID: 30373605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
